Pfizer earnings were $4.3B for the trailing 12 months ending Jun 28, 2026, with -59.8% growth year over year. The latest PFE earnings report on Jun 28, 2026 announced Q2 2026 earnings of -$248.0M, down 109.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PFE reported annual earnings of $7.8B, with -3.2% growth.
PFE past earnings growth
How has PFE's earnings growth performed historically?
On PFE's earnings call on Aug 4, 2026, Pfizer (NYSE: PFE) reported Q2 2026 earnings per share (EPS) of -$0.04, up 107.84% year over year. Total PFE earnings for the quarter were -$248.00 million. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.51.
As of the last Pfizer earnings report, Pfizer is currently profitable. Pfizer's net profit (also called net income) for the twelve months ending Jun 28, 2026 was $4.33 billion, a 59.69% decrease year over year.
What was PFE's earnings growth in the past year?
As of Pfizer's earnings date in Aug 4, 2026, Pfizer's earnings has grown -59.79% year over year. This is 89.53 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 29.75%. PFE earnings in the past year totalled $4.33 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.